Clinical trial Recruiting at 1 site Interventional Ages 18 to 45 Women only

Effect of a nutritional supplement on women with Polycystic Ovary Syndrome

Official title: Study of the Effect of a Nutritional Supplement on Microbiota, Metabolic Control, Inflammatory Profile, and Quality of Life in Patients With Polycystic Ovary Syndrome

Run by Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · NCT06551285 · Data updated 2026-11-12

This study is testing whether a nutritional supplement can help women with Polycystic Ovary Syndrome feel better and improve their health.

More Metabolic Syndrome trials

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexWomen only
Enrollment120 (estimated)
SponsorFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Academic / other
Locations1 site (Valencia, Valencia)
StatusRecruiting
StartedFebruary 1, 2024
Main results expectedDecember 31, 2026
Study endsMay 31, 2029
Registry record updatedMarch 17, 2026
Trial IDNCT06551285 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women aged 18 to 45 diagnosed with PCOS according to the AE-PCOS criteria.

Probably not a fit

Patients with severe organic diseases, diabetes, or those who have previously received treatment for PCOS may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of a nutritional supplement on the microbiota, metabolic control, inflammatory profile, and quality of life in women diagnosed with Polycystic Ovary Syndrome (PCOS). It focuses on patients aged 18 to 45 who meet specific diagnostic criteria for PCOS. The study aims to assess how the supplement may improve insulin sensitivity and reduce symptoms associated with PCOS, which can include metabolic syndrome and related health risks. Participants will be monitored for changes in their health and quality of life throughout the intervention.

Why it matters

Potential benefit: If successful, this study could provide a new nutritional approach to managing symptoms and improving the quality of life for women with PCOS.

How similar studies have gone: While there have been studies exploring nutritional interventions in PCOS, this specific approach focusing on microbiota and metabolic control is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged between 18 and 45 years.
* Patients diagnosed with PCOS using the AE-PCOS diagnostic criteria (2009).
* Patients who agree to participate in the study and sign the informed consent form after reading it.

Exclusion Criteria:

* Having been treated with medication or supplementation aimed at improving PCOS prior to the study (e.g., metformin, hormonal therapy, inositol, etc.).
* Suffering from an infectious, hematological, inflammatory, or autoimmune disease.
* Having a severe organic disease.
* Suffering from cardiovascular disease (heart attack, ischemia, thromboembolism).
* Diabetes Mellitus.
* Severe arterial hypertension.
* Alcoholism.
* Active smoking.

Where it's running

  • Fisabio
    Valencia, Valencia, Spain
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.